분자유전학실험실 (단국대학교 분자생물학과)

 이성욱 ( 2013-07-20 07:31:07 , Hit : 2084
 Stem cells reprogrammed using chemicals alone

Patient-specific cells could be made without genetic manipulation.

David Cyranoski 18 July 2013

Turning human cells into stem cells without changing their genes could lead to therapies that do not carry a risk of generating mutations.

Andrew Brookes/Corbis
Article toolsPrint


Rights & Permissions









Scientists have demonstrated a new way to reprogram adult tissue to become cells as versatile as embryonic stem cells — without the addition of extra genes that could increase the risk of dangerous mutations or cancer.

Researchers have been striving to achieve this since 2006, when the creation of so-called induced pluripotent (iPS) cells was first reported. Previously, they had managed to reduce the number of genes needed using small-molecule chemical compounds, but those attempts always required at least one gene, Oct42, 3.

Now, writing in Science, researchers report success in creating iPS cells using chemical compounds only — what they call CiPS cells1.

Related stories
Stem cells cruise to clinic
Safety of induced stem cells gets a boost
Cell rewind wins medicine Nobel
More related stories
Hongkui Deng, a stem-cell biologist at Peking University in Beijing, and his team screened 10,000 small molecules to find chemical substitutes for the gene. Whereas other groups looked for compounds that would directly stand in for Oct4, Deng's team took an indirect approach: searching for small-molecule compounds that could reprogram the cells in the presence of all the usual genes except Oct4.

Then came the most difficult part. When the group teamed the Oct4 replacements with replacements for the other three genes, the adult cells did not become pluripotent, or able to turn into any cell type, says Deng.

The researchers tinkered with the combinations of chemicals for more than a year, until they finally found one that produced some cells that were in an early stage of reprogramming. But the cells still lacked the hallmark genes indicating pluripotency. By adding DZNep, a compound known to catalyse late reprogramming stages, they finally got fully reprogrammed cells, but in only very small numbers. One further chemical increased efficiency by 40 times. Finally, using a cocktail of seven compounds, the group was able to get 0.2% of cells to convert — results comparable to those from standard iPS production techniques.

The team proved that the cells were pluripotent by introducing them into developing mouse embryos. In the resulting animals, the CiPS cells had contributed to all major cell types, including liver, heart, brain, skin and muscle.

“People have always wondered whether all factors can be replaced by small molecules. The paper shows they can,” says Rudolf Jaenisch, a cell biologist at the Whitehead Institute for Biomedical Research in Cambridge, Massachusetts, who was among the first researchers to produce iPS cells. Studies of CiPS cells could give insight into the mechanisms of reprogramming, says Jaenisch.

The frog's secret
The achievement could even help regenerative biologists to work out how amphibians grow new limbs. Deng’s group found that one gene indicative of pluripotency, Sall4, was expressed much earlier in the CiPS-cell reprogramming process than in iPS-cell reprogramming. The same Sall4 involvement is seen in frogs that regenerate a lost a limb4: before the regeneration, cells in the limb de-differentiate, a process akin to reprogramming, and Sall4 is active early in that process.

The discovery “provides an important framework to decipher the signalling pathways leading to Sall4 expression” in regulating limb regeneration, says Anton Neff, who studies organ regeneration at Indiana University in Bloomington.

Sheng Ding, a reprogramming researcher at the Gladstone Institutes in San Francisco, California, says that the study marks “significant progress” in the field, but notes that chemical reprogramming is unlikely to be used widely until the team can show that it can work for human cells, not just mouse ones. Other strategies, including one that uses RNA, can complete reprogramming with less risk of disturbing the genes than the original iPS-generation method, and are already in use in humans. Indeed, clinical trials with iPS cells derived through such means are already being planned.

Deng has made some progress towards using his method in human cells, but it will require tweaks. ”Maybe some additional small molecules are needed,” he says.

If it the technique is found to be safe and effective in humans, it could be useful for the clinic. It does not risk causing mutations, and the compounds themselves seem to be safe — four of them are in fact already in clinical use. The small molecules can easily pass through cell membranes, so they can be washed away after they have initiated the reprogramming.

Journal name:
Hou, P. et al. Science http://dx.doi.org/10.1126/science.1239278 (2013).

PubMedISIShow context
Zhu, S. et al. Cell Stem Cell 7, 651–655 (2010).

ArticlePubMedISIChemPortShow context
Li, Y. et al. Cell Res. 21, 196–204 (2011).

ArticlePubMedISIChemPortShow context
Neff, A. W., King, M. W. & Mescher, A. L. Dev. Dynam. 240, 979–989 (2011).

707   Potential New Target to Thwart Antibiotic Resistance: Viruses in Gut Confer Antibiotic Resistance to Bacteria  이성욱 2013/06/13 2259
706   Biotech industry worries over Supreme Court DNA ruling  이성욱 2013/06/15 2229
705   유전자 특허 불인정 판결의 후폭풍: 멘붕에 빠진 미 BT 업계  이성욱 2013/06/20 2928
704   복제연구를 둘러싼 논쟁  이성욱 2013/06/21 2039
703   日, 유도만능줄기세포 임상연구 세계 최초 승인  이성욱 2013/06/27 2264
702   생물학적 주기 및 대사 유전자의 간섭과 연관되어 있는 프라더-윌리 증후군  이성욱 2013/06/28 3241
701   ‘젊은 유전자’로 안티에이징.. 파괴적 혁신 기술이 미용·항노화산업 발달 촉진  이성욱 2013/07/01 3116
700   줄기세포로 사람 '肝씨앗' 만들어 자라게… 日 세계 첫 성공  이성욱 2013/07/04 2197
699   줄기세포 이식으로 HIV 감염 완치: 세계 3번째, 4번째의 HIV 완치 환자 등장  이성욱 2013/07/05 2846
698   암 전이(metastasis)로 통하는 문을 공략하라  이성욱 2013/07/09 2382
697   Scientists develop ground-breaking new method of 'starving' cancer cells  이성욱 2013/07/15 2341
696   Gene therapy using HIV helps children with fatal diseases, study says  이성욱 2013/07/16 2018
695   Scientists find way to silence extra chromosome that causes Down syndrome  이성욱 2013/07/20 2213
  Stem cells reprogrammed using chemicals alone  이성욱 2013/07/20 2084
693   다운증후군 원인 염색체 침묵화 가능성 확인  이성욱 2013/07/22 2258
692    "여성 X염색체에 정자생산 관여 유전자 존재"  이성욱 2013/07/23 2227
691   Giant viruses open Pandora's box  이성욱 2013/07/26 2026
690   유전자 돌연변이 외에 게놈의 상호작용  이성욱 2013/08/06 2203
689   박테리아로 박테리아 제압한다  이성욱 2013/08/07 2440
688   잠 못 자면 살찌는 이유’  이성욱 2013/08/07 2095

[이전 10개] [1]..[21][22][23][24][25][26][27][28] 29 [30]..[64] [다음 10개]

Copyright 1999-2022 Zeroboard / skin by ROBIN